Shorter DAPT Tested Following CABG - Scorecard - MDSpire

Shorter DAPT Tested Following CABG

TOP-CABG compared 3 months vs 12 months of ticagrelor plus aspirin following bypass surgery.

  • By

  • Kathryn Wighton

  • June 8, 2026

  • 6 min

Share

Clinical Scorecard: Shorter DAPT Tested Following CABG

At a Glance

CategoryDetail
Condition
Key MechanismsTicagrelor-based dual antiplatelet therapy (DAPT) for reducing SVG occlusion and bleeding risk.
Target Population
Care Setting

Key Highlights

  • Emphasize the clinical relevance of the noninferiority findings for SVG occlusion.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Monitor for SVG occlusion and bleeding events within 1 year, including specific imaging techniques.

      Risks

        Patient & Prescribing Data

        Detail patient selection criteria for the 3-month DAPT strategy.

        Clinical Best Practices

        • Include a note on excluding patients unable to tolerate early postoperative DAPT.

        Related Resources & Content

        Original Source(s)

        Shorter DAPT Tested Following CABG

        • by Kathryn Wighton

        • June 8, 2026

        Related Content

        Hereditary transthyretin amyloid cardiomyopathy caused by the rare TTR p.Ser43Asn variant in an Asian family: a case report

        Ensitrelvir Reduced COVID After Household Exposure

        In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

        FDA Monthly Preview: Key June Decisions to Watch

        Several FDA decisions across multiple specialties are expected this month.